Research ExplorerScientific StaffChristoffer Gebhardt

Univ. Prof. Dr. ID: 5526253

Christoffer Gebhardt

graph of relations
Affiliations
Links
ORCID: 0000-0001-7090-9584

Publications

C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study: Addendum

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Age matters: Rethinking SLNB's reliability in melanoma mortality prediction

Research output: SCORING: Contribution to journal › Comment/debate › Research

Erfolgreiche Behandlung eines Checkpoint‐Inhibitor‐assoziierten bullösen Pemphigoids mit Dupilumab bei Angiosarkom

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Successful treatment of refractory checkpoint inhibitor-induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab

Research output: SCORING: Contribution to journal › Case report › Research › peer-review

Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (105)

projects

Promotionsstipendium Zell

Project: Research

Promotionsstipendium Zimmermann

Project: Research

CPDR001J2201 Novartis

Project: Research

View all (3)

activities

Roggenbuck-Stiftung (External organisation)

Activity: Membership › Bodies of private companies and organisations

Hiege-Stiftung gegen Hautkrebs (External organisation)

Activity: Membership › Bodies of private companies and organisations

Arbeitsgemeinschaft Dermatologische Forschung (ADF) (External organisation)

Activity: Membership › Learned societies and special interest organisations › Research

Arbeitsgemeinschaft Dermatologische Onkologie (ADO) (External organisation)

Activity: Membership › Learned societies and special interest organisations › Research

33. Deutscher Hautkrebskongress der Arbeitsgemeinschaft Dermatologische Onkologie (ADO)

Activity: Participating in or organising an event › Participation in conferences › Research

31. Deutscher Hautkrebskongress der Arbeitsgemeinschaft Dermatologische Onkologie (ADO)

Activity: Participating in or organising an event › Participation in conferences › Research

J DTSCH DERMATOL GES (Journal)

Activity: Publication peer-review and editorial work › Editor of journals › Research

J EUR ACAD DERMATOL (Journal)

Activity: Publication peer-review and editorial work › Editor of journals › Research

View all (8)